MW Microbes World Microbial Science & Research
Revised on 18 October 2026

Viruses occupy an unusual position in biology. They carry genetic information, evolve through mutation and natural selection, and can transform the biology of the organisms they infect. Yet a virus particle does not grow, divide, or produce its own proteins as a bacterial or eukaryotic cell does. Viral multiplication occurs inside susceptible host cells, where viral genes and cellular machinery work together, sometimes to the host's considerable disadvantage.

The word virus derives from a Latin term historically associated with poison. Early investigators recognized infectious agents that passed through filters able to retain many bacteria, but size and filterability are not reliable definitions today. Modern virology studies viruses of bacteria and archaea as well as those infecting plants, fungi, protists and animals. These viruses differ in genome type, structure, replication strategy, and their effects on hosts.

Figure 1. Structural diversity of viruses. This image was generated by AI for Microbes World.

How virology developed

Late nineteenth-century filtration experiments with tobacco mosaic disease helped establish that some infectious agents differed from known bacteria. Twentieth-century advances in electron microscopy, cell culture and bacteriophage genetics then made virus structures and replication experimentally accessible. Discoveries in reverse transcription, viral oncogenes, molecular cloning and genome sequencing transformed viruses from elusive pathogens into powerful systems for investigating molecular biology. Today, high-throughput sequencing has extended the field to viruses that have never been isolated in laboratory culture.

What is a virus?

A virus is an infectious genetic entity that depends on host cells for its multiplication. The extracellular particle, called a virion, typically packages a DNA or RNA genome within a protein shell. Many virions also carry a lipid envelope, viral proteins or enzymes needed early in infection. The genome does not normally contain the full apparatus for ribosome-based protein synthesis. Consequently, viruses must access cellular translation machinery and obtain energy and building materials from the host.

The statement that viruses are 'not alive' is a useful introductory shorthand, but it hides a philosophical and biological debate. A virion is metabolically inactive outside a cell, whereas an infected cell can become a highly organized site of viral gene expression, replication and assembly. Viruses are unambiguously evolving biological entities; whether they should count as living organisms depends on how life is defined. They are also not the same as bacteria, which are cells able to carry out their own protein synthesis.

Virus particles: genomes, capsids and envelopes

The viral genome contains instructions needed for multiplication and transmission. It may be double-stranded DNA, single-stranded DNA, double-stranded RNA or single-stranded RNA, with some viruses using reverse transcription. Genomes may be linear or circular, continuous or segmented. Influenza viruses, for example, have segmented RNA genomes; HIV has an RNA genome but copies it into DNA as part of its life cycle. These differences help explain how different viruses reproduce and evolve.

A capsid is the protein shell built from repeating subunits that protects the genome and helps deliver it to a host. The term nucleocapsid refers to the genome packaged with its protein components; in some viruses this consists of a discrete capsid and in others a genome–protein assembly. Many animal viruses acquire a lipid envelope from cellular membranes during assembly or release; viral proteins embedded in the envelope often mediate host-cell entry. Enveloped viruses can be vulnerable to agents that disrupt lipids, although stability varies widely by virus and environmental conditions. Some virions also carry polymerases, proteases or other enzymes necessary to initiate infection.

Figure 2. Comparison of enveloped and non-enveloped virus particles. Non-enveloped viruses contain a nucleic acid genome protected by a protein capsid, whereas enveloped viruses possess an additional lipid membrane, generally acquired from the host cell, with viral proteins involved in attachment and entry. The illustration represents generalized structures; individual viruses may contain additional components and was created by AI for Microbes World.

How viral shapes differ

The familiar morphological patterns are icosahedral, helical and complex. Icosahedral capsids organize protein subunits in a roughly spherical, symmetrical shell; helical nucleocapsids arrange proteins around nucleic acid; and complex architectures include some head-and-tail bacteriophages and poxviruses. A spherical appearance does not necessarily mean that a capsid itself is spherical: an enveloped virus may appear rounded even when its underlying nucleocapsid has another arrangement. Filamentous bacteriophages, including M13-like phages, should not be depicted as head-and-tail phages.

Many virus particles are tens to hundreds of nanometres in size, but exceptions are important. Giant viruses infecting eukaryotic microorganisms may have particles comparable in size to small bacteria and genomes with hundreds or thousands of genes. Despite their size and expanded gene repertoires, giant viruses are not independent cells: they still depend on cellular hosts for crucial functions, including protein synthesis.

Figure 3. Common morphological forms of viruses. Viruses display different structural arrangements, including helical nucleocapsids, icosahedral capsids, enveloped particles, and complex head-and-tail bacteriophages. Viral morphology reflects the organization of structural proteins and, in some cases, the presence of an outer lipid envelope. This figure was generated by AI for Microbes World.

How virologists classify viruses

Two approaches answer different questions. The Baltimore classification organizes viruses into seven groups according to genome type and, crucially, how viral messenger RNA is produced. Formal ICTV taxonomy instead assigns viruses to evolutionary groups, including species and higher ranks, using genetic, structural and other evidence. Baltimore groups are not equivalent to species, families or evolutionary lineages. This distinction prevents a common misunderstanding in introductory virology.

Baltimore groupGenome or strategyRepresentative example
IDouble-stranded DNA (dsDNA)Adenoviruses; many tailed bacteriophages
IISingle-stranded DNA (ssDNA)Parvoviruses
IIIDouble-stranded RNA (dsRNA)Rotaviruses
IVPositive-sense single-stranded RNA (+ssRNA)Poliovirus; coronaviruses
VNegative-sense single-stranded RNA (−ssRNA)Influenza virus; rabies virus
VISingle-stranded RNA with reverse transcriptionHIV and other retroviruses
VIIDNA genome with an RNA intermediate and reverse transcriptionHepatitis B virus

A positive-sense RNA genome can often serve directly as mRNA after entry; a negative-sense RNA genome must first be copied into a readable positive-sense RNA by an RNA-dependent RNA polymerase, normally brought into the virion. Double-stranded RNA viruses also require specialized viral transcription machinery. Reverse-transcribing viruses use DNA and RNA intermediates in ways that do not follow the simplest DNA-to-RNA model. These are fundamental mechanistic differences, not merely alternative naming conventions.

The International Committee on Taxonomy of Viruses (ICTV) regularly revises official classification as sequence data and phylogenetic analyses expand. Its 2025 taxonomy release, ratified in February 2026, recognizes 17,554 virus species and ten realms. These are numbers of classified taxa in a particular release–not estimates of every virus in nature. An enormous proportion of environmental viral diversity remains uncultured or incompletely characterized.

The viral replication cycle: a shared framework

No single life cycle applies to every virus, but a useful framework comprises attachment, entry, uncoating or genome delivery, gene expression and genome replication, assembly and maturation, and release. The steps may overlap, occur in different cellular compartments or proceed without producing immediately detectable extracellular virions. Importantly, virus multiplication is not binary fission: new genomes and structural components are produced and then combined into infectious particles.

Figure 4. General stages of viral replication in a host cell. A simplified replication cycle illustrating viral attachment, entry and uncoating, genome replication, viral protein synthesis, assembly of new particles and release. The sequence and cellular locations of these events vary among virus groups, depending on genome type, replication strategy and host-cell biology. This figure was generated by AI for Microbes World.

Attachment and host range

For infection to begin, viral structures must interact with compatible molecules on a cell or find another route to gain entry. Receptors and co-receptors help determine host range and tissue tropism, but entry alone does not guarantee productive infection. Cellular restriction factors, immune responses and availability of replication machinery can make a cell nonpermissive even when viral binding occurs. Bacteriophages can recognize bacterial surface proteins, lipopolysaccharides or pili; some animal viruses enter by membrane fusion or receptor-mediated endocytosis.

Genome expression and replication

After genome delivery, the virus must generate functional mRNA, replicate its nucleic acid and synthesize proteins. DNA viruses often use the host nucleus and may depend partly on cellular polymerases, but poxviruses perform much of their replication in the cytoplasm. Most RNA viruses replicate in cytoplasmic compartments, whereas influenza viruses have important nuclear steps. Viral polymerases may introduce mutations, and replication and proofreading fidelity vary substantially among lineages. Host factors remain essential even when viruses encode many of their own enzymes.

Assembly, maturation and release

Capsid proteins and genomes must meet and form infectious particles, often through regulated pathways involving scaffolding proteins, packaging motors, proteolytic maturation or host factors. Assembly can have self-organizing components, but it is incorrect to say that every virus assembles completely spontaneously without cellular assistance. Release also differs: some bacteriophages lyse bacteria using dedicated lysis proteins; filamentous phages can be secreted without immediate killing; many enveloped animal viruses bud through membranes; and some viruses spread directly between neighbouring cells.

Bacteriophages: lytic, temperate and persistent infections

Bacteriophages, or phages, infect bacteria. Classic virulent phages can follow a productive pathway that ends with host lysis and release of progeny. In contrast, temperate phages can establish a state of lysogeny in which a viral genome, or prophage, is maintained within a bacterial lineage. A prophage is frequently integrated into the chromosome, but some persist as extrachromosomal elements. Environmental or cellular signals may induce a switch toward productive multiplication in certain systems.

The two familiar lytic-versus-lysogenic diagrams are important teaching tools but do not capture the full range of virus-microbe relationships. Chronic release, carrier states and other persistent interactions occur, and infection can alter bacterial metabolism or competitive ability without immediately destroying the cell. Phages also facilitate transduction, the transfer of bacterial DNA between cells, and some carry genes that change bacterial virulence. The CTXφ phage carrying cholera toxin genes in Vibrio cholerae is a classic example of phage-associated pathogenicity.

Viruses of plants, animals and other eukaryotes

Viruses of animals include pathogens transmitted by respiratory, gastrointestinal, blood-borne and other routes, as well as viruses that do not cause recognized disease. Infection outcomes range from asymptomatic carriage and brief acute illness to chronic infection, latency or severe disease. Herpesviruses can establish latency, while HIV establishes persistent infection through reverse transcription and genomic integration. Viral presence does not automatically mean clinical disease; symptoms emerge from a combination of viral replication, tissue damage, host immunity and other factors.

Plant viruses commonly spread via insect vectors, propagation material, wounds or other routes that bypass protective cell walls. Many are RNA viruses and spread between plant cells through plasmodesmata, sometimes aided by viral movement proteins. Virus-induced plant diseases can reduce crop yield, but symptoms and transmission mechanisms vary. Fungi, protists and algae also host diverse viruses; some may alter ecological behaviour without producing an obvious disease phenotype.

Viruses infecting archaea include unusual particle shapes and replication strategies that challenge models drawn only from animal viruses and bacterial phages. This diversity is a reason to avoid describing one type of phage as the universal virus blueprint.

Viral evolution, recombination and emergence

Virus evolution is driven by mutation, natural selection, genetic drift, recombination and, in segmented viruses, reassortment when compatible genomes share a cell. These processes influence host adaptation, immune escape and resistance to antiviral drugs. Their rates and consequences depend on the virus and ecological setting: RNA genomes often accumulate substitutions rapidly, but 'all RNA viruses mutate rapidly' is too simplistic. Recombination and reassortment differ, and not every mutation benefits the virus.

A host jump can create an emerging infection, but successful emergence also requires appropriate host exposures, replication compatibility and transmission opportunities. Wildlife surveillance, ecological research and genomic epidemiology can help identify changes, yet detection of a virus sequence alone does not establish its ability to infect or spread in humans.

Viral disease, immunity and public health

Viral diseases affect humans, domestic animals, wildlife and crops. Respiratory infections, viral gastroenteritis, hepatitis, immunodeficiency and virus-associated cancers illustrate different mechanisms of harm. Some viruses are transmitted through aerosols or respiratory droplets, some through blood or sexual contact, others through contaminated food or water, arthropod vectors or direct contact. Reliable prevention depends on the biology of the agent and its route of transmission.

Innate antiviral responses include interferon signalling and intracellular sensors of viral nucleic acids. Adaptive immunity involves antiviral antibodies and virus-specific T cells, but protection varies by pathogen, prior exposure and immune condition. Vaccination can prevent infection or reduce disease severity for many viruses, while antiviral medicines target particular stages of replication. Antibiotics do not act against viruses themselves, although bacterial co-infections may require separate treatment. Diagnostics can use PCR or other nucleic-acid tests, antigen detection, serology or culture where appropriate; a positive nucleic-acid result is not always equivalent to infectiousness.

The World Health Organization's 2024 global hepatitis report demonstrates the continuing burden of hepatitis B and C and the importance of vaccination, testing and access to treatment. Public-health priorities should be tied to current surveillance and authoritative guidance rather than general claims that every virus causes severe illness.

Viruses as ecological and evolutionary agents

Viruses are abundant in aquatic and terrestrial ecosystems and in the microbiomes of animals. Their infection of bacteria, archaea, algae and other hosts can influence population dynamics, nutrient release and microbial evolution. Viral lysis may release cellular organic matter back into microbial food webs, often called the viral shunt. Yet the magnitude of such effects varies with habitat and cannot be inferred simply from a virus count. Phage–bacterium relationships include predation-like antagonism, gene transfer and context-dependent persistence.

Sequencing studies have uncovered vast numbers of viral sequences from seawater, soils and host-associated samples. Most of those sequences alone do not establish which organism is infected, whether a virus is infectious or what it does environmentally. Recent work linking single-cell transcriptomes with giant-virus sequences illustrates how scientists are beginning to identify host associations more directly rather than assigning functions from sequence similarity alone.

Beneficial uses of viruses in science and biotechnology

Viruses are powerful tools for studying cellular processes, gene regulation and evolution. Engineered viral vectors deliver genes in research and some approved gene therapies, although delivery efficiency, immune responses and safety require careful evaluation. Vaccine platforms may use inactivated viruses, attenuated viruses, viral components or viral vectors. Bacteriophages are being investigated for targeted control of bacterial infections, food contamination and biofilms; their suitability depends on host range, bacterial resistance, safety and rigorous clinical evidence.

Phage display can link proteins or peptides to their encoding DNA, making it valuable for selecting molecular binders. Viral enzymes, capsids and replication systems also support molecular biology and nanotechnology. These applications demonstrate that the biomedical importance of viruses extends well beyond their role as pathogens.

Viruses, viroids and prions are not the same

Viroids are small infectious RNA molecules that cause certain plant diseases and lack the typical protein capsid of a virus. Prions are infectious misfolded proteins associated with transmissible spongiform encephalopathies; they do not carry a conventional nucleic-acid genome. Satellite nucleic acids and other virus-dependent genetic elements provide further examples of infectious entities that do not fit the familiar autonomous virion model. Distinguishing these agents is useful because their modes of replication, transmission and detection differ.

How scientists study viruses

Electron microscopy and cryogenic electron microscopy reveal virus architecture and protein structure. Cell culture, plaque assays and other infectivity measurements test whether viruses can multiply under defined conditions. PCR, quantitative PCR, sequencing and metagenomics identify viral genetic material, while proteomics and transcriptomics study viral products and interactions. Each method answers a different question: finding a genome sequence does not prove active infection, and an image of a particle does not necessarily identify its species or infectivity.

Cultivating viruses can be difficult because they require suitable hosts and conditions. Metagenomics has expanded discovery dramatically, but also introduces challenges in contamination control, assembling genomes, distinguishing viruses from other mobile elements, and associating viruses with hosts. A robust interpretation combines sequence-based results with experimental, ecological or clinical evidence whenever possible.

What recent virology research is changing

Three research areas particularly broaden the traditional textbook view. First, the ICTV's expanding classification shows that viruses cannot be organized adequately by shape or host alone. Second, studies of giant viruses have revealed unexpectedly large genomes and complex host relationships, challenging simplistic rules about viral size and gene content. Third, environmental and single-cell approaches show that viruses often influence microbial communities through more varied relationships than immediate host destruction.

An important open question is how to connect the huge catalogue of viral sequences to demonstrated ecological functions, host specificity and evolutionary history. Similar caution applies to medicine: genomic variation may raise new hypotheses about transmission or drug resistance, but those conclusions need appropriate epidemiological or experimental evidence.

Conclusion

Viruses are genetically diverse infectious entities whose multiplication depends on cells, but they are not all built alike and do not all follow a single destructive life cycle. Their structure and genome dictate how they enter hosts, make proteins, replicate and spread. They influence health, agriculture, microbial evolution and global ecosystems, and they have become valuable tools for biotechnology.

References

1. Chevallereau, A., Pons, B. J., van Houte, S., & Westra, E. R. (2022). Interactions between bacterial and phage communities in natural environments. Nature Reviews Microbiology, 20, 49–62. https://doi.org/10.1038/s41579-021-00602-y

2. Correa, A. M. S., Howard-Varona, C., Coy, S. R., Buchan, A., Sullivan, M. B., & Weitz, J. S. (2021). Revisiting the rules of life for viruses of microorganisms. Nature Reviews Microbiology, 19, 501–513. https://doi.org/10.1038/s41579-021-00530-x

3. Fromm, A., Hevroni, G., Vincent, F., Schatz, D., Martinez-Gutierrez, C. A., Aylward, F. O., & Vardi, A. (2024). Single-cell RNA-seq of the rare virosphere reveals the native hosts of giant viruses in the marine environment. Nature Microbiology, 9, 1619–1629. https://doi.org/10.1038/s41564-024-01669-y

4. Harvey, E., & Holmes, E. C. (2022). Diversity and evolution of the animal virome. Nature Reviews Microbiology, 20, 321–334. https://doi.org/10.1038/s41579-021-00665-x

5. International Committee on Taxonomy of Viruses. (2026). Virus taxonomy: 2025 release (MSL41). https://ictv.global/taxonomy

6. Parker, N., Schneegurt, M., Tu, A.-H. T., Lister, P., & Forster, B. M. (2016). Microbiology (Chapter 6: Acellular pathogens). OpenStax. https://openstax.org/books/microbiology/pages/6-introduction

7. Schulz, F., Abergel, C., & Woyke, T. (2022). Giant virus biology and diversity in the era of genome-resolved metagenomics. Nature Reviews Microbiology, 20, 721–736. https://doi.org/10.1038/s41579-022-00754-5

8. Suttle, C. A. (2007). Marine viruses—major players in the global ecosystem. Nature Reviews Microbiology, 5, 801–812. https://doi.org/10.1038/nrmicro1750

9. World Health Organization. (2024). Global hepatitis report 2024: Action for access in low- and middle-income countries. https://www.who.int/publications/i/item/9789240091672

No comments:

Post a Comment

Contact Microbes World

Name

Email *

Message *